SoFi Members Get Access to Private AI Stocks

This new access to private AI companies arrives as the digital health funding landscape rebounds, with investment reaching $14.2 billion in 2025, the highest since 2022. A significant portion of this capital, 54%, was captured by AI-enabled startups, which commanded nearly a 19% premium on average deal size compared to their non-AI counterparts. This investor focus on AI underscores the technology's perceived potential to revolutionize healthcare. Successful consumer health apps like Flo, which boasts over 60 million active users and high retention rates, demonstrate the power of AI-driven personalization. These apps leverage AI to tailor content and messaging to individual user behavior, creating a more engaging and effective experience. Growth strategies for these apps often involve a multi-pronged approach, including robust content marketing, SEO, and influencer partnerships to build community and trust. For a founder entering the consumer health space, understanding data privacy is critical. While many assume wellness apps are covered by HIPAA, the reality is more nuanced. Direct-to-consumer health apps that collect information directly from users generally fall outside of HIPAA's scope. However, they are still subject to other regulations, such as the FTC's Health Breach Notification Rule and various state privacy laws, making transparency with users paramount. Building trust with health-conscious consumers, particularly those with chronic conditions, requires more than just a seamless user interface. It involves transparent data practices and, increasingly, taking a stand on issues that matter to the community. Insights from patient advocacy blogs like "The Patient Advocate's Chronicle" and "Chronic Eileen" can provide invaluable understanding of the patient journey and the language that resonates with this audience. The longevity and biohacking space is also seeing a surge in interest and investment, with a focus on extending "healthspan." Startups in this arena are exploring cellular reprogramming, senolytics, and NAD+ metabolism, backed by prominent tech investors. Recent breakthroughs in 2025 include research identifying the biological age of the brain and immune system as key predictors of a long and healthy life. For a solo technical founder, the journey from developer to CEO involves navigating not only product development but also the intricacies of fundraising and brand building. The current digital health market is characterized by larger, more concentrated funding rounds, creating a "haves and have-nots" dynamic. This makes a compelling narrative and a clear go-to-market strategy as crucial as the underlying technology.